PINP as a biological response marker during teriparatide treatment for osteoporosis
John H. Krege(Eli Lilly (United States)), Paul D. Miller(University of Colorado Health), Nancy E. Lane(University of California Davis Medical Center), Jennifer Harris(Eli Lilly (United States))
Cited by 164
Related Papers
Generation and reproductive phenotypes of mice lacking estrogen receptor β
|Proceedings of the National Academy of Sciences|1998|1.7k
Elevated blood pressures in mice lacking endothelial nitric oxide synthase
|Proceedings of the National Academy of Sciences|1996|903
Gut microbiome pattern reflects healthy ageing and predicts survival in humans
|Nature Metabolism|2021|668